Increased levels of Tribbles homolog 2 (TRIB2) autoantibodies, which specifically target hypocretin neurons, have been observed in patients with narcolepsy, and high levels of these antibodies ...

Narcolepsy is a life-long disease characterized by fragmented sleep which manifests primarily as excessive daytime sleepiness and cataplexy—sudden and uncontrollable muscle weakness or paralysis.

Horsnell has narcolepsy, a sleep disorder that makes it hard to stay awake for long periods. Not only will a person fall asleep repeatedly during the day, but they will have extremely disrupted ...

A three-decade series of coincidences will likely help doctors treat narcolepsy — and possibly prevent opioid addiction — and ...

Awakened Hope for Narcolepsy — ITT Episode 17: In this podcast episode, a patient with narcolepsy describes her rough, long road to diagnosis and treatment, and a researcher elucidates both the ...

Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is ...

Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...